7 November 2023 - Sage Therapeutics has priced the oral post partum depression pill it developed with partner Biogen at $15,900 for a full 14 day course of treatment, the company said on Tuesday, months after the drug was approved by the US health regulator.

The companies had sought US approval for Zurzuvae to treat clinical depression, a much larger market, and postpartum depression, but the FDA in August approved it only for PPD.

Read Reuters article